Published online before print August 7, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
regulates Toll-like receptor-mediated IL-27 gene expression in human macrophagesDepartment of Viral Diseases and Immunology, National Public Health Institute, Helsinki, Finland
1 Correspondence: Department of Viral Diseases and Immunology, National Public Health Institute, Mannerheimintie 166, FI-00300, Helsinki, Finland. E-mail: jaana.pirhonen{at}ktl.fi
IL-27 is a novel member of the IL-12 cytokine family. IL-27 has pro- and anti-inflammatory properties, and it controls the responses of adaptive immunity. It promotes the differentiation of naïve Th cells and suppresses the effector functions of Th17 cells. Biologically active IL-27 is a heterodimer composed of EBV-induced gene 3 (EBI3) and p28 proteins. We report that TLR-dependent expression of IL-27 in human macrophages is mediated by IFN-
. Stimulation of macrophages with agonists for TLR3 {polyinosinic:polycytidylic acid [poly(I:C)]}, TLR4 (LPS), or TLR7/8 (R848) results in concurrent expression of EBI3 and p28. The p28 expression is inhibited with neutralizing anti-IFN- antibodies. Unlike poly(I:C), LPS, and R848, TLR2 agonist (S)-[2,3-bis(palmitoyloxy)-(2RS)-propyl]-N-palmitoyl-(R)-Cys-(S)-Ser(S)-Lys4-OH trihydrochloride does not stimulate macrophages to produce IFN-, and therefore, it is not able to turn on the expression of p28. There is an IFN-stimulated response element (ISRE) in the p28 gene promoter. IFN- enhances the expression of IFN regulatory factor 1 (IRF-1) in macrophages and induces binding of IRF-1 to the p28 ISRE site. The data provide a mechanistic basis for the IFN--mediated activation of IL-27. The data emphasize a role of IFN- in immune responses, which rely on the recognition of pathogens by TLRs.
Key Words: interferon regulatory factor • IFN-stimulated response element • transcriptional activation • viral infection
This article has been cited by other articles:
 |
|
 |
|
  C. Molle, M. Goldman, and S. Goriely Critical Role of the IFN-Stimulated Gene Factor 3 Complex in TLR-Mediated IL-27p28 Gene Expression Revealing a Two-Step Activation Process J. Immunol., February 15, 2010; 184(4): 1784 - 1792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yoshida, M. Nakaya, and Y. Miyazaki Interleukin 27: a double-edged sword for offense and defense J. Leukoc. Biol., December 1, 2009; 86(6): 1295 - 1303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tanaka, T. Yoshimoto, T. Naka, S. Nakae, Y.-i. Iwakura, D. Cua, and M. Kubo Natural Occurring IL-17 Producing T Cells Regulate the Initial Phase of Neutrophil Mediated Airway Responses J. Immunol., December 1, 2009; 183(11): 7523 - 7530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Greenwell-Wild, N. Vazquez, W. Jin, Z. Rangel, P. J. Munson, and S. M. Wahl Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon Blood, August 27, 2009; 114(9): 1864 - 1874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhang, J. Jin, Y. Tang, D. Speer, D. Sujkowska, and S. Markovic-Plese IFN-{beta}1a Inhibits the Secretion of Th17-Polarizing Cytokines in Human Dendritic Cells via TLR7 Up-Regulation J. Immunol., March 15, 2009; 182(6): 3928 - 3936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vultaggio, F. Nencini, P. M. Fitch, L. Fili, L. Maggi, P. Fanti, A. deVries, E. Beccastrini, F. Palandri, C. Manuelli, et al. Modified Adenine (9-Benzyl-2-Butoxy-8-Hydroxyadenine) Redirects Th2-Mediated Murine Lung Inflammation by Triggering TLR7 J. Immunol., January 15, 2009; 182(2): 880 - 889. [Abstract] [Full Text] [PDF]
|
|
